Position in CRSP
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$63,030
-$6,453 QoQ
Shares Held
1,325
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PITTENGER & ANDERSON INC holds $106,331 across 8 Biotechnology names. CRSP ranks #1 (59.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
This page
|
1,325 | $63,030 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
612 | $20,330 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,000 | $14,820 | |
| 4 | CRMD |
CorMedix Inc.
|
610 | $4,141 | |
| 5 | EXEL |
Exelixis, Inc.
|
80 | $3,431 | |
| 6 | ATNM |
Actinium Pharmaceuticals, Inc.
|
341 | $339 | |
| 7 | INO |
Inovio Pharmaceuticals, Inc.
|
77 | $133 | |
| 8 | ELDN |
Eledon Pharmaceuticals, Inc.
|
35 | $107 |
All Filings in CRSP
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,030 | 1,325 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $69,483 | 1,325 | Shares | Sole | 2026-02-02 | |
| 2021-09-30 | $4,029 | 36 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,047 | 25 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,071 | 17 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,602 | 17 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $920 | 11 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||